Houses of Parliament with Big Ben and double-decker buses on Westminster bridge
Biotech

British biotechs mull going public after yearslong IPO drought

Could this be the year U.K.-based biotechs rediscover the allure of the public markets?
James Waldron Jan 26, 2026 1:01am
bacteria and virus science on chalkboard

US vaccine landscape ‘100%’ impacting business: Bancel

Jan 23, 2026 1:26pm
artistic visualization of genome data genetics

J. Craig Venter launches genomics startup

Jan 23, 2026 8:50am
dusk parachute

BMS snags top neuro researcher from Eisai—Chutes & Ladders

Jan 23, 2026 8:30am
success failure signposts

Sanofi posts mixed phase 3 data on key eczema prospect

Jan 23, 2026 5:43am
dominoes stop stall halt end red

NIH bans use of aborted fetal tissue in research

Jan 22, 2026 2:27pm
More News

Hoth strikes back against skin toxicities but stock stays frozen

Jan 22, 2026 10:38am

Corxel secures $287M series D to fund oral GLP-1 studies

Jan 22, 2026 10:22am

Corcept racks up ph. 3 cancer win to bounce back from FDA blow

Jan 22, 2026 9:45am

Fierce Biotech Fundraising Tracker 2026: Corxel, Mendra & more

Jan 22, 2026 9:30am